Mallinckrodt plc has announced plans to acquire Stratatech Corporation, a regenerative medicine company that develops proprietary skin substitute products.

The acquisition is expected to strengthen Mallinckrodt’s overall business.

Scintilla Pharmaceuticals Inc, a subsidiary of Sorrento Therapeutics Inc, has announced the acquisition of pharmaceutical company Semnur Pharmaceuticals Inc for a purchase consideration of up to $200m.

Scintilla is a provider of the resiniferatoxin programme for the treatment of opiate refractory cancer pain. The transaction is expected to help Scintilla to expand its pain management pipeline.

Lonza Group Ltd has acquired InterHealth Nutraceuticals Inc, a provider of nutritional ingredients for use in dietary supplements, for $300m.”

Lonza Group Ltd has acquired InterHealth Nutraceuticals Inc, a provider of nutritional ingredients for use in dietary supplements, for $300m.

The acquisition is expected to help Lonza to support its nutritional ingredients portfolio and also expand its business into the cognitive and diabetic health segments.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Active With Me Inc has merged with Rasna Therapeutics Inc in a reverse takeover transaction. The new company will be named as Rasna Therapeutics Inc.

SASMAR Pharmaceuticals S.P.R.L. has announced the acquisition of Aquatrove Biosciences through its Australian subsidiary SASMAR Healthcare Pty Ltd.

Aquatrove is a biotechnology company focused on the human reproductive health and fertility areas. The transaction is expected to strengthen Sasmar’s product pipelines and build its position in over-the-counter products in the health, fertility and reproduction segments.